Neuro-Oncology News

So-called “liquid biopsies” — noninvasive tests used to evaluate blood for cancer cells or DNA — have been refined extensively over the past decade, leading to a growing number of applications in cancer treatment.

The FDA cleared an investigational new drug application for CYNK-001, a natural killer cell therapy, for the treatment of glioblastoma multiforme.

Dolores Hambardzumyan, PhD, MBA, has been appointed senior faculty in the department of neurosurgery and member of The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai.

Adults in Taiwan exposed to radiation from CT scans demonstrated increased risk for thyroid cancer and leukemia, according to results of a nested case-control study published in JNCI Cancer Spectrum.

An international study of glioblastoma revealed a cellular pathway that appears to contribute to glioma stem cell spread and proliferation.

Cancer mortality rates dropped by 29% between 1991 and 2017 in the United States, with a 2.2% drop between 2016 and 2017, according to according to data from Cancer Statistics 2020, American Cancer Society’s annual report on cancer rates and trends.

Proton chemoradiotherapy appeared associated with a substantial reduction in acute adverse events that caused unplanned hospitalizations compared with traditional photon chemoradiotherapy among adults with locally advanced cancer, according to results of a retrospective study published in JAMA Oncology.

The use of frozen embryo transfer in women was linked to a small but statistically significant increased risk for childhood cancer compared with children born to fertile women, according to recent findings.

The FDA and European Medicines Agency granted orphan drug designation to zotiraciclib for the treatment of glioma, according to the agent’s manufacturer.

The Partnership for Aging and Cancer Research Program awarded seven grants intended to fund research into the link between aging and cancer.